Rapid COVID-19, Flu A/B Testing: What You Need to Know
Respiratory illnesses like COVID-19, influenza A, and influenza B share similar symptoms, making accurate diagnosis crucial for appropriate treatment and preventing further spread. Rapid testing options are now available that can simultaneously detect all three viruses, providing quick results to guide medical decisions.
Understanding the Importance of Combined Testing
COVID-19 continues to pose a risk, even for vaccinated individuals. Symptoms overlap significantly with those of influenza A and B, and even other respiratory infections like strep throat. Testing for all potential causes simultaneously streamlines diagnosis and ensures patients receive the correct care. Delaying appropriate treatment can worsen illness and increase the risk of complications.
Available Rapid Tests: A Comparison
Several rapid tests combine detection of SARS-CoV-2 (the virus that causes COVID-19), influenza A, and influenza B. Two prominent options include:
- Status™ COVID-19/Flu A&B Rapid Antigen Test: This test, authorized for professional use by the FDA under Emergency Use Authorization (EUA), provides visual results in 15-20 minutes. It requires a nasopharyngeal swab and is intended for use in point-of-care settings by organizations with CLIA certification. Source
- BinaxNOW™ COVID-19/Flu A&B: Utilizing a single nasal swab, this test simultaneously detects COVID-19, influenza A, and influenza B, delivering results in 15 minutes. It is designed for professional use. Source
How Rapid Tests Perform
Both the Status™ and BinaxNOW™ tests are lateral flow immunoassays. This means they detect specific antigens – proteins – from the viruses in a nasal swab sample. The tests are qualitative, meaning they indicate whether or not the antigen is present, rather than quantifying the amount of virus. Source
Test Accuracy and Interpretation
It’s important to understand the accuracy of these tests:
- Status™ COVID-19/Flu A&B: Demonstrates 93.9% sensitivity and 100.0% specificity for SARS-CoV-2, 91.4% sensitivity and 95.7% specificity for Flu A, and 87.6% sensitivity and 95.9% specificity for Flu B. Source
Sensitivity refers to the test’s ability to correctly identify positive cases, although specificity refers to its ability to correctly identify negative cases. False negative results are possible, meaning a person infected with a virus may test negative. False positive results are less common but can occur.
Where to Acquire Tested
These tests are typically administered in healthcare settings, such as doctor’s offices, urgent care centers, and hospitals. The Status™ test requires CLIA certification for use.
What to Do After Testing
If you test positive for COVID-19 or the flu, it’s important to follow public health guidelines, which may include isolating yourself from others, wearing a mask, and seeking medical attention if symptoms worsen. Your healthcare provider can discuss appropriate treatment options.
Key Takeaways
- Rapid tests can simultaneously detect COVID-19, influenza A, and influenza B.
- These tests are valuable for quick diagnosis and appropriate treatment.
- Test accuracy varies, and false negative results are possible.
- Professional medical guidance is essential for interpreting results and managing illness.